Advertisement
Canada markets closed

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7322
    -0.0001 (-0.01%)
     

  • CRUDE OIL

    83.85
    +0.28 (+0.34%)
     

  • Bitcoin CAD

    87,957.41
    +262.50 (+0.30%)
     

  • CMC Crypto 200

    1,392.63
    +10.06 (+0.73%)
     

  • GOLD FUTURES

    2,346.60
    +4.10 (+0.18%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,763.75
    +196.25 (+1.12%)
     

  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     

  • FTSE

    8,078.86
    +38.48 (+0.48%)
     

  • NIKKEI 225

    37,780.35
    +151.87 (+0.40%)
     

  • CAD/EUR

    0.6825
    +0.0004 (+0.06%)
     

CORRECTION FROM SOURCE: BTV Examines the Rapidly Expanding Psychedelics Market

Newsfile Corp.
·1 min read

Vancouver, British Columbia--(Newsfile Corp. - August 17, 2021) - On Sun. Aug. 22nd at 5pm EST broadcast on FOX Business News — BTV-Business Television explores the burgeoning sector that has captured the attention of investors - psychedelics.



Cannot view this video? Visit:
https://b-tv.com/btv-examines-the-rapidly-expanding-psychedelics-market-ep-362/

Discover Companies to Invest In - Click company name to watch their TV feature:

Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) — Researching and developing DMT, one of the most powerful psychedelics in existence, to address substance use disorders related to nicotine, alcohol, and opioids. Elemer Piros, Analyst at Roth Capital Partners, weighs in.

ADVERTISEMENT

Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) — BTV reports on their pre-clinical studies underway with a proprietary extract from the Amanita Muscaria mushroom.

Small Pharma Inc. (TSXV: DMT) — BTV learns about DMT, a psychedelic that is the subject of a Small Pharma clinical trial dealing with depression — the world's first.

Numinus Wellness Inc. (TSXV: NUMI) — BTV checks in with a company at the forefront of a new and innovative mental health treatment focused on psychedelic assisted psychotherapy.

Mydecine Innovations Group (NEO: MYCO) (OTC Pink: MYCOF) — BTV discovers how this company is developing psilocybin-based psychedelic treatments to better address the affects of addiction and post traumatic stress disorder.

On air for over 20 years, BTV - Business Television, a half-hour investment TV show, features analysts and emerging publicly traded companies at their location. With Hosts, Taylor Thoen and Jessica Katrichak, BTV provides viewers with investment opportunities.

Suggest a Company to Feature!
Contact: (604) 664-7401 x3 info@b-tv.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/92856